Anteris Technologies Global Corp.

Stage 3 · Topping · week 9

As of Oct 22, 2026, Anteris Technologies Global is in Stage 3, the topping phase, now in week 9 (since Aug 25, 2026). It closed at $6.00, 43.2% below its 52-week high and below its 200-day average, which is rising.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. More about the company

$6.00

-0.83% today

$585M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is AVR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-12-13 → 2026-10-22

S? 42w

S2 17w

S2 16w

S3 8w

2024-12-132026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S1 5w → S2 2w → S4 2w → S3 2w → S2 17w → S3 2w → S2 16w → S3 8w current

Total tracked: 97 weeks across 9 stage runs.

AVR among Medical Devices52nd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…52	AVRAnteris Technologies Global Corp.	Stage 3 · wk 9	50	−21.3%

vs 52W High

-43.2%

$3.38 lo$10.57 hi

43.2% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 9

1w13w26w

Week 9, distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

-18.3%

200 DMA: $7.35 · rising

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

2.13x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-21.3%

-26.2%

+8.5%

YTD

+22.0%

-5.5%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S3

Wk 9 · Vol 2.13x

2026-10-21S3

Wk 9 · Vol 1.06x

2026-10-20S3

Wk 8 · Vol 2.98x

2026-10-19S3

Wk 8 · Vol 1.46x

2026-10-16S3

Wk 8 · Vol 1.11x

2026-10-15S3

Wk 8 · Vol 0.89x

2026-10-14S3

Wk 8 · Vol 1.89x

2026-10-13S3

Wk 7 · Vol 0.82x

2026-10-12S3

Wk 7 · Vol 1.04x

2026-10-09S3

Wk 7 · Vol 1.43x

2026-10-08S3

Wk 7 · Vol 2.73x

2026-10-07S3

Wk 7 · Vol 2.77x

Moving averages & range

50 DMA

$7.95

200 DMA

$7.35

52W High

$10.57

52W Low

$3.38

5D Low

$6.00

Resistance levels (recent highs)

20d High

$7.77

60d High

$9.83

120d High

$10.57

250d High

$10.57

Next resistance

+29.5%

to 20d High

ROE

-74.7%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 2.3

Anteris Technologies Global: quick answers

What stage is Anteris Technologies Global in?

As of Oct 22, 2026, Anteris Technologies Global (AVR) is in Stage 3, the topping phase. It entered Stage 3 on Aug 25, 2026 and is in week 9. What the four stages mean

Is Anteris Technologies Global in an uptrend?

Its uptrend has stalled. Anteris Technologies Global is in Stage 3, the topping phase that follows an advance. It trades 18.3% below its 200-day average, which is rising.

How far is Anteris Technologies Global from its 52-week high?

Anteris Technologies Global closed at $6.00 on Oct 22, 2026, 43.2% below its 52-week high of $10.57. Its 52-week low is $3.38.

How has Anteris Technologies Global performed over the past year?

As of Oct 22, 2026, Anteris Technologies Global is down 5.5% over the past year and up 22.0% so far in 2026.

Which sector and industry is Anteris Technologies Global in?

Anteris Technologies Global is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.